ALTERITY THERAPEUTICS LTD
For the period ended Sep 30, 2026. Filed Sep 3, 2026.
View on SEC.govAbout this filing
What a company based outside the US has published at home or sent to its shareholders. It is how many foreign companies share results and news between annual reports.
Sep 30, 2026 · Filed Sep 3, 2026
Use the contents to explore the available documents and sections.
ATHE$2.43+9.5%Stored close · as of Nov 6, 2026
Contents
EX-99.1 · Authorization & Additional Information
Authorization & Additional Information
This announcement was authorized by David Stamler, CEO of Alterity Therapeutics Limited.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.